Regeneron Announces Presentation at the 24th Annual Credit Suisse Healthcare Conference

23 Oct, 2015, 09:30 ET from Regeneron Pharmaceuticals, Inc.

TARRYTOWN, N.Y., Oct. 23, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast its presentation at the 24th Annual Credit Suisse Healthcare Conference at 1:30 p.m. ET on Tuesday, November 10, 2015.

The session may be accessed through the Company's web site, www.regeneron.com, on the 'Events and Presentations' page.  Archived versions of the presentations will be available for 30 days.

About Regeneron Pharmaceuticals, Inc. Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron commercializes medicines for high LDL cholesterol, eye diseases, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including oncology, rheumatoid arthritis, asthma, atopic dermatitis, pain, and infectious diseases.  For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.

Contact Information:

Investor Relations

Corporate Communications

Manisha Narasimhan, Ph.D.

Hala Mirza

914.847.5126

914.847.3422             

manisha.narasimhan@regeneron.com

 hala.mirza@regeneron.com

SOURCE Regeneron Pharmaceuticals, Inc.



RELATED LINKS

http://www.regeneron.com